Fernando González‐Ortiz

Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring

Nicholas J. Ashton, Shorena Janelidze, Niklas Mattsson et al. · Nature Medicine · 2022 · 431 citations · Full text

Medicine, Clinical Sciences, Neurology +17

Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration

Fernando González‐Ortiz, Michael Turton, Przemysław R. Kac et al. · Brain · 2022 · 228 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Plasma and CSF biomarkers in a memory clinic: Head‐to‐head comparison of phosphorylated tau immunoassays

Nicholas J. Ashton, Albert Puig‐Pijoan, Marta Milà‐Alomà et al. · Alzheimer s & Dementia · 2022 · 224 citations · Full text

Medicine, Neurology, Neuroscience +17

A novel ultrasensitive assay for plasma p‐tau217: Performance in individuals with subjective cognitive decline and early Alzheimer's disease

Fernando González‐Ortiz, Pâmela C.L. Ferreira, Armand González‐Escalante et al. · Alzheimer s & Dementia · 2023 · 90 citations · Full text

Medicine, Neurology, Neuroscience +17

Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease

Yara Yakoub, Nicholas J. Ashton, Cherie Strikwerda‐Brown et al. · Alzheimer s & Dementia · 2023 · 81 citations · Full text

Medicine, Neurology, Neuroscience +17